These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2666594)

  • 1. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
    Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
    J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
    Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biochemical markers of central nervous system metastases.
    Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
    Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
    Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
    Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of cerebrospinal fluid biochemical markers of central nervous system metastases.
    Ongerboer de Visser BW; van Zanten AP; Twijnstra A; Nooyen WJ; Hart AA
    Prog Exp Tumor Res; 1985; 29():105-15. PubMed ID: 3906759
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid beta 2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases.
    Twijnstra A; van Zanten AP; Nooyen WJ; Hart AA; Ongerboer de Visser BW
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):387-91. PubMed ID: 3525181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
    Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
    JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer.
    Dearnaley DP; Patel S; Powles TJ; Coombes RC
    Oncodev Biol Med; 1981; 2(4):305-11. PubMed ID: 7301610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
    Wasserstrom WR; Glass JP; Posner JB
    Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Glantz MJ
    Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy.
    Jeffery GM; Frampton CM; Legge HM; Hart DN
    Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
    Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
    Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
    Jacobi C; Reiber H; Felgenhauer K
    J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
    Klee GG; Tallman RD; Goellner JR; Yanagihara T
    Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
    Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
    Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer.
    Pedersen AG; Bach FW; Nissen M; Bach F
    J Clin Oncol; 1985 Oct; 3(10):1364-72. PubMed ID: 2995599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.
    Twijnstra A; van Zanten AP; Hart AA; Ongerboer de Visser BW
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):313-20. PubMed ID: 3559613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.